Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
19.65 USD | +3.42% | +12.09% | +36.65% |
04-22 | Sector Update: Health Care Stocks Advance Premarket Monday | MT |
04-22 | Kura Oncology Gets Breakthrough Designation For Leukemia Therapy | DJ |
Evolution of the average Target Price on Kura Oncology, Inc.
Price target over the last 5 years
History of analyst recommendation changes
Analysts' Consensus
Consensus detail
Consensus revision (last 18 months)
Analysts covering Kura Oncology, Inc.
Mizuho Securities | |
Wedbush | |
BofA Securities | |
Scotiabank | |
Stifel Nicolaus | |
BTIG | |
Credit Suisse | |
Cantor Fitzgerald | |
SVB Leerink | |
Jefferies & Co. | |
HC Wainwright |
EPS Revisions
- Stock Market
- Equities
- KURA Stock
- Consensus Kura Oncology, Inc.